Entero Healthcare Solutions Reports Significant Growth in Profit and Sales for Q1 FY25
Entero Healthcare Solutions, a midcap IT software company, has recently announced its financial results for the quarter ended June 2024. The company has shown a very positive performance with a score of 26, which is a significant improvement from the previous score of 7 in the last 3 months.
One of the major highlights of the financial results is the significant growth in Profit After Tax (PAT) for the half-yearly period, which has increased by 1,528.97% year on year. This shows a very positive trend for the company’s profitability. Additionally, the Profit Before Tax less Other Income (PBT) for the quarter has also shown a growth of 162.3% compared to the average PBT of the previous four quarters. This indicates a positive trend in the near term for the company’s PBT.
Moreover, Entero Healthcare Solutions has also shown a strong ability to manage its interest payments, with the Operating Profit to Interest ratio being the highest in the last five quarters. The company’s Operating Profit (PBDIT) for the quarter has also been the highest at Rs 30.18 crore and has shown growth in each of the last five quarters, indicating a positive trend in the near term.
In terms of sales, the company has achieved its highest net sales of Rs 1,097.04 crore in the last five quarters, showing a positive trend in the near term. However, there are some areas that need improvement, such as the high percentage of Non-Operating Income in the Profit Before Tax (PBT) and the increased income from non-business activities, which may not be sustainable in the long run.
Overall, Entero Healthcare Solutions has shown a strong financial performance in the quarter ended June 2024, with positive trends in key areas such as PAT, PBT, and sales. Investors should keep an eye on the company’s progress in managing its non-business income and maintaining its profitability in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
